Hepta, a biotechnology company using transformer-based AI to read the cell-free DNA (cfDNA) epigenome and detect ...

Inclusion in the ENDO 1000 study in the UK for multiple sample types is presented as evidence of market validation for OraSure Technologies' collection kits, as described in the Q3 2025 earnings call, ...

Q3 2025 Earnings Call Transcript November 4, 2025 SOPHiA GENETICS S.A. misses on earnings expectations. Reported EPS is $-0.3 ...

Guardant Health, Inc. , a leading precision oncology company, today announced new real-world data published in Current Medical Research and Opinion finding that the Shield blood-based screening test ...

Introduction Excessive opioid prescribing after surgery can lead to adverse events and exacerbate the opioid crisis. Patients undergoing outpatient breast surgery are often prescribed opioids to ...

The acquisition, which enables Qiagen to enter the single-cell sequencing market, is expected to close in December and contribute $40 million to 2026 revenues.

Launched in 2019, the Syn-One Test is used by neurologists and other clinicians in all 50 states to aid in the diagnosis of synucleinopathies SCOTTSDALE, Ariz., /PRNewswire/ -- CND Life Sciences (CND) ...

Working with the same tumor slices that pathologists use to diagnose and guide treatment of patients, however, Carstens can ...

Thank you, operator, and welcome to all of you to who are joining us for this call for the third quarter 2025. In fact, the twenty-fourth consecutive quarter in which we met or exceeded our target.

A team of scientists is employing a technique used to detect invasive species to search for troops lost at sea.

Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...

According to Nova One Advisor, the global exosome research market size is calculated at USD 225.72 million in 2025 and is ...